Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz

News provided by

Jul 30, 2013, 06:30 ET

ALBANY, New York, July 30, 2013 /PRNewswire/ --

New Market Research Report Added in MarketResearchReports.Biz Reports Database Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline

GBI Research's report "Pain Management Therapeutics Market to 2019 Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline" provides insights and analysis into the market. Pain is a widespread problem across the world. More than 25% of the total population suffers from some clinically significant pain in a year. Since pain considerably affects day-to-day activities in life, its management presents a considerable challenge for physicians. Inadequate pain control remains a major problem across the world. There is an urgent and unmet need to manage these pain-related problems accurately. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In many cases, such as cancer pain, 50% of the people taking medicines are not satisfied with the results.

This is primarily due to the absence of a perfect pain management solution. Pain management can be most effective only when the underlying disease conditions are cured. However, there is no treatment that offers absolute relief for the indications covered in this report.

To Browse Full TOC, Tables & Figures visit: http://www.marketresearchreports.biz/analysis/171481

The medications given for these indications are more for modifying the disease symptoms than offering complete relief from pain. The combination of under-managed pain, low awareness, and fear of addiction to some classes of pain medication is preventing people suffering pain from seeking treatment 100% of the time.

Latest Reports

Microgrid Market

Geotextiles Market

Biopesticides Market

Personalized Medicine Diagnostics Market

Electrophoresis Equipment Market

Application Server Market

Middleware Messaging Marke

China Dissolving Pulp Market

China Rubber Auxiliary Industry

Liquid Macro Filtration Marke

Scope

Overview of the pain management market by analyzing the revenue, Annual Cost of Therapy (ACT) and treatment usage pattern across the top seven markets, which are the US, the UK, France, Germany, Spain, Italy and Japan.
Therapeutic landscape of the pain management therapeutics market and includes detailed market sizing and analysis of the trends in eight indications, which are fibromyalgia, neuropathic pain, cancer pain, Osteoarthritis (OA) pain, Rheumatoid Arthritis (RA) pain, migraine, Low Back Pain (LBP) and post-operative pain.
Geographical landscape of the pain management therapeutics market in the top seven markets, which are the US, the UK, France, Germany, Spain, Italy and Japan.
Detailed pipeline analysis of the pain management market (as of April 2013). The section also contains detailed analyses of the most promising pipeline molecules.
Profiles of the top companies operating in the pain management therapeutics market.
List of strategic consolidations, such as M&A deals, licensing agreements and partnership deals that took place in the global pain management therapeutics market between 2007 and 2013.

Latest Reports

Blood Processing Devices and Consumables Market

Gas Sensors Market

Coaxial Cable Market

Pain Management Devices Market

Data Center Construction Market

Country Specific Market Research Reports:

China Market Research Reports

United States Market Research Reports

Philippines Market Research Reports

Global Market Research Reports

Reasons to buy

Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
Devise a more tailored country strategy through the understanding of key drivers and barriers of the region's pain management therapeutics market.
Develop key strategic initiatives by understanding the key focus areas and top selling pain management therapeutics molecules of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Table of Contents

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 13

2 Pain Management Therapeutics Market to 2019 - Introduction 16

3 Pain Management Therapeutics Market to 2019 - Market Overview 17
3.1 Introduction 17
3.2 World Health Organization Pain Ladder 18
3.3 Risk Evaluation and Mitigation Strategy 19
3.4 Revenue 20
3.5 Major Marketed Pain Management Drugs 21
3.5.1 Abstral (fentanyl citrate) 21
3.5.2 Celebrex (celecoxib) 22
3.5.3 Cymbalta (duloxetine) 23
3.5.4 Exparel (Bupivacaine ER) 24
3.5.5 Lidoderm (lidocaine patch) 25
3.5.6 Lyrica (pregabalin) 26
3.5.7 Nucynta ER (tapentadol ER) 27
3.5.8 Qutenza (capsaicin) 28
3.5.9 Savella (milnacipran hydrochloride) 29
3.5.10 Vimovo (esomeprazole magnesium + naproxen) 30
3.5.11 Voltaren Gel (diclofenac sodium) 31
3.6 Annual Cost of Therapy 32
3.7 Treatment Usage Patterns 33
3.7.1 Prevalence Population 34
3.7.2 Diagnosed Population 34
3.7.3 Prescription Population 34
3.8 Drivers and Restraints of the Pain Management Therapeutics Market 35
3.8.1 Drivers 35
3.8.2 Restraints 36

4 Pain Management Therapeutics Market to 2019 - Therapeutic Landscape 37
4.1 Pain Management Therapeutics Market for Fibromyalgia 37
4.1.1 Introduction 37
4.1.2 Revenue 37
4.1.3 Annual Cost of Therapy 39
4.1.4 Treatment Flow Algorithm 40
4.1.5 Treatment Usage Pattern 41
4.1.6 Geographical Segmentation 43
4.1.7 Drivers and Restraints for the Fibromyalgia Market 44
4.1.8 Drivers 45
4.1.9 Restraints for the Fibromyalgia Pain Relief Market 45
4.2 Pain Management Therapeutics for Neuropathic Pain 46
4.2.1 Introduction 46
4.2.2 Revenue 46
4.2.3 Annual Cost of Therapy 48
4.2.4 Treatment Flow Algorithm 49
4.2.5 Treatment Usage Pattern 50
4.2.6 Geographical Segmentation 52
4.2.7 Drivers and Restraints for the Neuropathic Pain Market 53
4.2.8 Drivers 53
4.2.9 Restraints 54
4.3 Pain Management Therapeutics Market for Migraine 55
4.3.1 Introduction 55
4.3.2 Revenue 55
4.3.3 Annual Cost of Therapy 57
4.3.4 Treatment Flow Algorithm 58
4.3.5 Treatment Usage Pattern 59
4.3.6 Geographical Segmentation 61
4.3.7 Drivers and Restraints for the Migraine Market 62
4.3.8 Drivers 62
4.3.9 Restraints 62
4.4 Pain Management Therapeutics Market for Cancer Pain 63
4.4.1 Introduction 63
4.4.2 Revenue 64
4.4.3 Annual Cost of Therapy 65
4.4.4 Treatment Flow Algorithm 66
4.4.5 Treatment Usage Pattern 67
4.4.6 Geographical Segmentation 69
4.4.7 Drivers and Restraints for the Cancer Pain Market 70
4.4.8 Drivers 70
4.4.9 Restraints 71
4.5 Pain Management Therapeutics Market for Osteoarthritis Pain 72
4.5.1 Introduction 72
4.5.2 Revenue 72
4.5.3 Annual Cost of Therapy 74
4.5.4 Treatment Flow Algorithm 75
4.5.5 Treatment Usage Pattern 76
4.5.6 Geographical Segmentation 78
4.5.7 Drivers and Restraints for the Osteoarthritis Pain Market 79
4.5.8 Drivers 79
4.5.9 Restraints 79
4.6 Pain Management Therapeutics Market for Rheumatoid Arthritis Pain 80
4.6.1 Introduction 80
4.6.2 Revenue 80
4.6.3 Annual Cost of Therapy 82
4.6.4 Treatment Flow Algorithm 83
4.6.5 Treatment Usage Pattern 84
4.6.6 Geographical Segmentation 86
4.6.7 Drivers and Restraints for the Rheumatoid Arthritis Market 87
4.6.8 Drivers 87
4.6.9 Restraints 87
4.7 Pain Management Therapeutics Market for Low Back Pain 88
4.7.1 Introduction 88
4.7.2 Revenue 88
4.7.3 Annual Cost of Therapy 90
4.7.4 Treatment Flow Algorithm 91
4.7.5 Treatment Usage Pattern 92
4.7.6 Geographical Segmentation 94
4.7.7 Drivers and Restraints for the Low Back Pain Market 95
4.7.8 Drivers 95
4.7.9 Restraints 95
4.8 Pain Management Therapeutics Market for Post-operative Pain 96
4.8.1 Introduction 96
4.8.2 Revenue 97
4.8.3 Annual Cost of Therapy 98
4.8.4 Treatment Flow Algorithm 99
4.8.5 Treatment Usage Pattern 100
4.8.6 Geographical Segmentation 102
4.8.7 Drivers and Restraints for the Post-operative Pain Market 103
4.8.8 Drivers 103
4.8.9 Restraints 103

5 Pain Management Therapeutics Market to 2019 - Geographical Landscape 104
5.1 The US 105
5.1.1 Revenue 105
5.1.2 Annual Cost of Therapy 106
5.1.3 Treatment Usage Pattern 107
5.2 Top Five European Countries 109
5.2.1 Revenue 109
5.2.2 Annual Cost of Therapy 110
5.2.3 Treatment Usage Pattern 111
5.3 Japan 113
5.3.1 Revenue 113
5.3.2 Annual Cost of Therapy 114
5.3.3 Treatment Usage Pattern 115

6 Pain Management Therapeutics Market to 2019 - Asia-Pacific and China 117
6.1 India 117
6.1.1 Regulatory Landscape 117
6.1.2 Marketed Products 120
6.1.3 Company Profiling 121
6.2 China 125
6.2.1 Regulatory Landscape 125
6.2.2 Marketed Products 128
6.2.3 Company Profiling 128
6.3 Australia 129
6.3.1 Regulatory Landscape 129
6.3.2 Marketed Products 130
6.3.3 Company Profiling 131

7 Pain Management Therapeutics Market to 2019 - Pipeline Analysis 134
7.1 Introduction 134
7.1.1 Research and Development Pipeline - Fibromyalgia 136
7.1.2 Research and Development Pipeline - Neuropathic Pain 138
7.1.3 Research and Development Pipeline - Migraine 143
7.1.4 Research and Development Pipeline - Cancer Pain 146
7.1.5 Research and Development Pipeline - Osteoarthritis Pain 148
7.1.6 Research and Development Pipeline - Low Back Pain 150
7.1.7 Research and Development Pipeline - Post-operative Pain 152
7.2 Profiles of Key Late-Stage Drugs in the Pain Management Therapeutics Market 154
7.2.1 AmiKet 154
7.2.2 Civanex 155
7.2.3 Droxidopa 156
7.2.4 Posidur 157
7.2.5 Sativex 158
7.2.6 TNX-102 159
7.2.7 Tetrodotoxin 160

8 Pain Management Therapeutics Market to 2019 - Competitive Landscape 161
8.1 Pfizer Inc 161
8.1.1 Overview 161
8.1.2 Product Profile 161
8.2 Johnson & Johnson 162
8.2.1 Overview 162
8.2.2 Product Portfolio 162
8.3 Endo Pharmaceuticals 163
8.3.1 Overview 163
8.3.2 Product Portfolio 163
8.4 Forest Laboratories 164
8.4.1 Overview 164
8.4.2 Product Portfolio 164
8.5 Eli Lilly 164
8.5.1 Overview 164
8.5.2 Product Portfolio 165
8.6 Teva Pharmaceuticals (Cephalon, Inc.) 165
8.6.1 Overview 165
8.6.2 Product Portfolio 165
8.7 Purdue Pharma 166
8.7.1 Overview 166
8.7.2 Product Portfolio 166

9 Pain Management Therapeutics Market to 2019 - Strategic Consolidations 168
9.1 Overview 168
9.1.1 M&A Deals by Year 168
9.1.2 M&A Deals by Indication 169
9.1.3 Recent Deals 170
9.2 Licensing Agreements 171
9.2.1 Deals by Year 171
9.2.2 Deals by Indication 172
9.2.3 Deals by Phase 173
9.2.4 Recent Licensing Deals 174
9.3 Partnership Deals 175
9.3.1 Deals by Year 175
9.3.2 Deals by Indication 176
9.3.3 Recent Partnership Deals 177

10 Management Therapeutics Market to 2019 - Appendix 178
10.1 Market Definitions 178
10.2 Abbreviations 178
10.3 Bibliography 180
10.4 Research Methodology 182
10.4.1 Coverage 182
10.4.2 Secondary Research 182
10.4.3 Primary Research 183
10.5 Therapeutic Landscape 183
10.5.1 Market 185
10.6 Geographical Landscape 186
10.7 Pipeline Analysis 186
10.8 Competitive Landscape 186
10.8.1 Expert Panel Validation 186
10.9 Contact Us 186
10.10 Disclaimer 186

Table 1: Pain Management Therapeutics Market, Top Seven Markets, Revenue ($bn), 2006-2012 20
Table 2: Pain Management Therapeutics Market, Top Seven Markets, Revenue Forecast ($bn), 2012-2019 20
Table 3: Pain Management Therapeutics Market, Top Seven Markets, Annual Cost of Therapy ($), 2006-2012 32
Table 4: Pain Management Therapeutics Market, Top Seven Markets, Annual Cost of Therapy Forecast ($), 2012-2019 32
Table 5: Pain Management Therapeutics Market, Top Seven Markets, Treatment Usage Pattern (million), 2006-2012 33
Table 6: Pain Management Therapeutics Market, Top Seven Markets, Treatment Usage Pattern Forecast (million), 2012-2019 34
Table 7: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Revenue ($bn), 2006-2012 38
Table 8: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Revenue Forecast ($bn), 2012-2019 38
Table 9: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Annual Cost of Therapy ($), 2006-2012 39
Table 10: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Annual Cost of Therapy Forecast ($), 2012-2019 39
Table 11: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Treatment Usage Pattern (Million), 2006-2012 41
Table 12: Pain Management Therapeutics Market, Top Seven Markets, Fibromyalgia, Treatment Usage Pattern Forecast (Million), 2012-2019 41
Table 13: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Revenue ($bn), 2006-2012 46
Table 14: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Revenue Forecast ($bn), 2012-2019 47
Table 15: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Annual Cost of Therapy ($), 2006-2012 48
Table 16: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Annual Cost of Therapy Forecast ($), 2012-2019 48
Table 17: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Treatment Usage Pattern (million), 2006-2012 50
Table 18: Pain Management Therapeutics Market, Top Seven Markets, Neuropathic Pain, Treatment Usage Pattern Forecast (million), 2012-2019 50
Table 19: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Revenue ($bn), 2006-2012 55
Table 20: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Revenue Forecast ($bn), 2012-2019 56
Table 21: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Annual Cost of Therapy ($), 2006-2012 57
Table 22: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Annual Cost of Therapy Forecast ($), 2012-2019 57
Table 23: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Treatment Usage Pattern (million), 2006-2012 59
Table 24: Pain Management Therapeutics Market, Top Seven Markets, Migraine, Treatment Usage Pattern Forecast (million), 2012-2019 60
Table 25: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Revenue ($bn), 2006-2012 64
Table 26: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Revenue Forecast ($bn), 2012-2019 64
Table 27: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Annual Cost of Therapy ($), 2006-2012 65
Table 28: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Annual Cost of Therapy Forecast ($), 2012-2019e 65
Table 29: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Treatment Usage Pattern (million), 2006-2012 67
Table 30: Pain Management Therapeutics Market, Top Seven Markets, Cancer Pain, Treatment Usage Pattern Forecast (million), 2012-2019 67
Table 31: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Revenue ($bn), 2006-2012 73
Table 32: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Revenue Forecast ($bn), 2012-2019 73
Table 33: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Annual Cost of Therapy ($), 2006-2012 74
Table 34: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Annual Cost of Therapy Forecast ($), 2012-2019 74
Table 35: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Treatment Usage Pattern (million), 2006-2012 76
Table 36: Pain Management Therapeutics Market, Top Seven Markets, Osteoarthritis Pain, Treatment Usage Pattern Forecast (million), 2012-2019 76
Table 37: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Revenue ($bn), 2006-2012 80
Table 38: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Revenue Forecast ($bn), 2012-2019 81
Table 39: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Annual Cost of Therapy ($'000), 2006-2012 82
Table 40: Pain Management Therapeutics Market, Top Seven Markets, Rheumatoid Arthritis Pain, Annual Cost of Therapy Forecast ($'000), 2012-2019 82

Upcoming Reports

Voice Recognition Technologies Market

Multimedia Chipsets Market

MIMO and Spread Spectrum Systems Market

Social TV Market

About Us

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Email: [email protected]
http://www.marketresearchreports.biz/
http://www.europlat.org/
http://businessindustryreports.wordpress.com/
http://bccresearchreports.blogspot.com/